Position in EDIT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$384,805
-$377 QoQ
Shares Held
155,792
-17.1% QoQ
Ownership
0.101%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 0%
Shared 99%
None 1%
Common Shares in EDIT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $5,060,262,064 across 202 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,604,822 | $1,293,893,227 | |
| 2 | INSM |
INSMED Inc
|
6,179,571 | $658,865,856 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,215,523 | $292,904,576 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,039,702 | $194,715,388 | |
| 5 | ARGX |
Argenx SE
|
181,464 | $168,356,853 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
227,457 | $141,828,535 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
231,205 | $124,145,521 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,551,663 | $115,567,858 |
All Filings in EDIT
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $384,805 | 155,792 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $385,182 | 187,894 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $652,858 | 188,144 | Shares | Defined | 2025-11-14 | |
| 2024-12-31 | $289,062 | 227,609 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $202,809 | 59,475 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $176,100 | 37,709 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $235,777 | 31,776 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $389,700 | 38,470 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $103,084 | 13,216 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $158,427 | 19,250 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $424,052 | 58,490 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $1,723,076 | 194,259 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,454,535 | 200,534 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $539,779 | 45,628 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $898,048 | 47,216 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $1,394,219 | 52,513 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,452,957 | 35,369 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,788,443 | 49,231 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,553,244 | 36,982 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,776,797 | 25,343 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $310,034 | 11,049 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $415,864 | 14,059 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $443,814 | 22,381 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||